Some of the content on this page has been created using generative AI.
What is it about?
The study investigates the impact of simultaneous transurethral resection of bladder tumour (TURB) and transurethral resection of the prostate (TURP) on perioperative and oncological outcomes. It found that simultaneous TURB and TURP seems to be a safe procedure that might potentially prevent recurrence, and this was true for patients with an increased risk of recurrence. The study also found comparable length of stay and complication rates for the TURB-alone vs TURB+TURP groups, while the latter led to longer operative times and was associated with TURP-specific events.
Featured Image
Why is it important?
This research is important as it provides the largest multicentre study investigating the impact of simultaneous TURB and TURP on perioperative and oncological outcomes. The study confirms the improved recurrence-free survival (RFS) in patients undergoing simultaneous procedure based on real-world generalized data including variable types of surgeries, tumour characteristics, and postoperative standards of care. Key Takeaways: 1. Simultaneous TURB and TURP appears to be a safe procedure that may potentially prevent recurrence, especially in patients with an increased risk of recurrence. 2. The study observed comparable length of stay and complication rates for the TURB-alone vs TURB+TURP groups, while the latter led to longer operative times and was associated with TURP-specific events. 3. Simultaneous TURB+TURP may lead to a decrease in bladder cancer recurrence as well as a delay in the time to recurrence.
AI notice
Read the Original
This page is a summary of: Oncological and safety profiles in patients undergoing simultaneous transurethral resection (TUR) of bladder tumour and TUR of the prostate, BJU International, October 2022, Wiley,
DOI: 10.1111/bju.15898.
You can read the full text:
Contributors
Be the first to contribute to this page







